Removing Pfizer's Chantix Boxed Warning A One-Off, Committee Says

Advisory committee says data supports dialing back safety label for the smoking cessation product, but shouldn’t be precedent setting.

RubberStampWarning_1200x675

Advisory committee members recommended removing the boxed warning from Pfizer Inc.'s smoking cessation drug Chantix, but were worried about the precedent it could set.

More from US FDA Performance Tracker

More from Regulatory Trackers